Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review
Tom Wai‐Hin Chung(Queen Mary Hospital), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Ming‐Yen Ng(Chinese University of Hong Kong), Kwok-Cheung Lung(Pamela Youde Nethersole Eastern Hospital), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Pauline Yeung Ng, Alan Wu(Pamela Youde Nethersole Eastern Hospital), Vincent Chi‐Chung Cheng(Queen Mary Hospital), Jinxia Zhang(Peking University), Zhimeng Fan(Tsinghua University), Hang‐Long Li(University of Hong Kong), Andrew Chak-Yiu Lee(Hong Kong Science and Technology Parks Corporation), Ivan Fan-Ngai Hung(University of Hong Kong), Ronnie S.L. Ho(Queen Mary Hospital), Sonia Hiu-Yin Lam(Queen Mary Hospital), Shiobhon Y Luk(Pamela Youde Nethersole Eastern Hospital), Kwok‐Hung Chan(University of Hong Kong), Raymond King‐Yin Tsang(University of Hong Kong), W. Kan(Pamela Youde Nethersole Eastern Hospital), Fergus Kai-Chuen Wong(Pamela Youde Nethersole Eastern Hospital), Sau-Man Leung(University of Hong Kong), Siddharth Sridhar(Queen Mary Hospital)
Cited by 114
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k